Substance P as a Biomarker to Evaluate the Reduction of Multiple Immunization Pain
1 other identifier
interventional
132
1 country
1
Brief Summary
Immunization is one of the most significant preventive health measures in reducing morbidity and mortality caused by infectious diseases. Studies have shown that Sucrose is recommended to reduce pain associated with vaccination in neonates. The main aim of the study was to determine the effectiveness of sucrose in reducing infant's pain outcomes during immunization among 10-24 month-old infants and toddlers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 14, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
April 3, 2018
CompletedFirst Submitted
Initial submission to the registry
October 17, 2018
CompletedFirst Posted
Study publicly available on registry
September 25, 2019
CompletedSeptember 25, 2019
September 1, 2019
5 months
October 17, 2018
September 24, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
MBPS
Modified Behavioral Pain Scale (MBPS) is a validated procedural uni-dimensional pain measurement tool that used to measure behavioral pain outcomes.
Change MBPS score from the start of injection and up to 3 minutes after immunization
Secondary Outcomes (1)
Substance P (SP)
Change SP level from the start of injection and up to 3 minutes after immunization
Other Outcomes (1)
Total crying time
From start of injection and up to 3 minutes after the immunization
Study Arms (2)
Sucrose group
EXPERIMENTALThis group received the 2 ml of sweet solution (sucrose)
Water group
PLACEBO COMPARATORThis group received the 2 ml of water
Interventions
Participants in the intervention group were given 2 ml dose of 50% sucrose solution and participants in the placebo group were given 2 ml dose of sterile water. Both groups were administered slowly over 30 seconds sublingually via needle-less syringe immediately prior to the immunization injections.
Eligibility Criteria
You may qualify if:
- All healthy children who were attending immunization clinic to have their 10-24 month immunization were invited to this study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Maternal and child health centers
Irbid, 21110, Jordan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Manal K, PhD
Jordan Uinversity of Sceince and Technology
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 17, 2018
First Posted
September 25, 2019
Study Start
July 14, 2017
Primary Completion
December 20, 2017
Study Completion
April 3, 2018
Last Updated
September 25, 2019
Record last verified: 2019-09
Data Sharing
- IPD Sharing
- Will not share
The data is confidential and could not be shared.